Iambic Therapeutics, Inc.
IAM Nasdaq
SEC CIK 1997038
Follow Iambic Therapeutics
Weekly email: filings, results
Revenue, last quarter
$11.4M
+141.9% vs same quarter last year
Net income
−$38.5M
−79.5% vs same quarter last year
EPS, diluted
−$8.52
−62.6% vs same quarter last year
Operating income
−$30.1M
−33.1% vs same quarter last year
Source: SEC XBRL filings · latest filing